admin

In what is being heralded as a breakthrough for cancer research, GW Pharmaceuticals announced on Tuesday positive results from a study using a combination of cannabidiol and tetrahydrocannabinol to treat an aggressive form of brain cancer. Glioblastoma multiforme, or GBM is a “particularly aggressive brain tumor, with a poor prognosis,” according to the British-based biopharmaceutical company focused on […]

by

Many cannabis consumers have experienced the infamous red eye. The eyes are often the most common giveaway after a serious session with a vaporizer. But how does cannabis affect overall eye health? Yet, while some may find the herb’s visible effects on the eyes to be burdensome, there are several surprising ways that cannabis supports […]

by

Shares of PreveCeutical Medical Inc. are expected to begin trading on the Canadian Securities Exchange on July 14 under the symbol PREV. The company, named after its focus on preventative nutraceuticals, has a pipeline that includes a cannabidiol-infused soluble gel delivery system and a dual-gene therapy targeting obesity and diabetics. In April, PreveCeutical formed a […]

by

NEW YORK, August 11, 2017 /PRNewswire/ — If you want a Stock Review on PCRX, EGRX, NEOS, or ZYNE then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today, DailyStockTracker.com takes note of the most recent performances of Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), Eagle Pharmaceuticals Inc. (NASDAQ: EGRX), Neos Therapeutics […]

by

Zynerba Pharmaceuticals Inc. reported a failed clinical trial for cannabidiol gel in adult epilepsy, which caused its stock to plummet 58.5 percent this week. The Zynerba trial found that ZYN002 did not demonstrate a statistically significant reduction of focal seizures during the treatment period. Armando Anido, chief executive officer of Zynerba, said: “We are very […]

by

Cannabinoid Hyperemesis Syndrome, or CHS for short, is a very rare condition that can occur in long-term, heavy cannabis users. Common criteria includes recurrent episodes of nausea and vomiting, dehydration, emergency room visits, and frequent bathing. Many believe that the increased popularity of concentrates is to blame, although studies show that CHS existed before they […]

by

Growing medical cannabis. Credit: Tilray Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century. However, with the loosening of laws regarding medical marijuana, research and clinical use of marijuana-derived substances are increasing. This has prompted the editors of Epilepsy Behavior to produce a […]

by

An unnamed Israel-based CRO has been contracted by Axim to conduct clinical trials on two different cannabis chewing gum products. A contract research organization, or CRO, is an organization that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. The details of the […]

by

(Photo by Scott Olson/Getty Images) I remember back in 2000, my headline was something like, “Get Ready For The RFID Retail Revolution,” or, “Wal-Mart Kicks Off The RFID Revolution.” Turns out the revolution never materialized. But it might this time around; at least that’s what retailers are hoping. After nearly 20 years of aborted takeoffs—including a much-watched failed […]

by

– Epidiolex® NDA submission process underway – – Conference call today at 4:30 p.m. EDT – LONDON and CARLSBAD, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results […]

by